Keywords
Last Name
Institution

WILLIAM PAUL GLEZEN

TitleDistinguished Emeritus Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleDistinguished Emeritus Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pediatrics
    DivisionPediatrics-Administration


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Glezen WP. Editorial commentary: Changing epidemiology of influenza B virus. Clin Infect Dis. 2014 Dec 1; 59(11):1525-6. PMID: 25139967.
      View in: PubMed
    2. Atmar RL, Piedra PA, Patel SM, Greenberg SB, Couch RB, Glezen WP. Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness. J Clin Microbiol. 2012 Feb; 50(2):506-8. PMID: 22116142; PMCID: PMC3264172.
    3. Glezen WP. Broadening indications for maternal influenza vaccination. J Infect Dis. 2011 Oct 15; 204(8):1151-3. PMID: 21917885.
      View in: PubMed
    4. Glezen WP. Cell-culture-derived influenza vaccine production. Lancet. 2011 Feb 26; 377(9767):698-700. PMID: 21329970.
      View in: PubMed
    5. Glezen WP. How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Clin Infect Dis. 2010 Dec 15; 51(12):1380-2. PMID: 21067354.
      View in: PubMed
    6. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010 Dec 1; 202(11):1626-33. PMID: 21028955; PMCID: PMC2974041.
    7. Glezen WP. Containing the novel influenza A (H1N1) virus. Clin Infect Dis. 2010 Mar 15; 50(6):869-70. PMID: 20136408.
      View in: PubMed
    8. Mouzoon ME, Munoz FM, Greisinger AJ, Brehm BJ, Wehmanen OA, Smith FA, Markee JA, Glezen WP. Improving influenza immunization in pregnant women and healthcare workers. Am J Manag Care. 2010 Mar; 16(3):209-16. PMID: 20225916.
      View in: PubMed
    9. Glezen WP. Benefits of a universal influenza immunization program: more than the reduction in the use of antibiotics. Clin Infect Dis. 2009 Sep 1; 49(5):757-8. PMID: 19624279.
      View in: PubMed
    10. Glezen WP. Respiratory syncytial virus: back to basics. J Allergy Clin Immunol. 2009 Feb; 123(2):404-5. PMID: 19121859.
      View in: PubMed
    11. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med. 2008 Dec 11; 359(24):2579-85. PMID: 19073977.
      View in: PubMed
    12. Glezen WP. Universal influenza vaccination and live attenuated influenza vaccination of children. Pediatr Infect Dis J. 2008 Oct; 27(10 Suppl):S104-9. PMID: 18820568.
      View in: PubMed
    13. Glezen WP. Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J. 2008 Aug; 27(8):738-43. PMID: 18664986.
      View in: PubMed
    14. Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect Dis J. 2008 May; 27(5):444-52. PMID: 18401289.
      View in: PubMed
    15. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007 Sep; 120(3):e553-64. PMID: 17698577.
      View in: PubMed
    16. Halloran ME, Piedra PA, Longini IM, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine. 2007 May 16; 25(20):4038-45. PMID: 17395338; PMCID: PMC2883284.
    17. Glezen WP. Asthma, influenza, and vaccination. J Allergy Clin Immunol. 2006 Dec; 118(6):1199-206; quiz 1207-8. PMID: 17157648.
      View in: PubMed
    18. Glezen WP. Herd protection against influenza. J Clin Virol. 2006 Dec; 37(4):237-43. PMID: 17008123.
      View in: PubMed
    19. Glezen WP. Influenza control. N Engl J Med. 2006 Jul 6; 355(1):79-81. PMID: 16823001.
      View in: PubMed
    20. Hite LK, Glezen WP, Demmler GJ, Munoz FM. Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis. 2007 Jan; 11(1):40-7. PMID: 16678464.
      View in: PubMed
    21. Glezen WP. A response to strategy #2: streamlining the regulatory process. Clin Infect Dis. 2006 Mar 1; 42 Suppl 3:S141-4. PMID: 16447137.
      View in: PubMed
    22. Glezen WP, Simonsen L. Commentary: benefits of influenza vaccine in US elderly--new studies raise questions. Int J Epidemiol. 2006 Apr; 35(2):352-3. PMID: 16368723.
      View in: PubMed
    23. Washington ML, Humiston SG, Fauerbach PB, Glezen WP, Black S, Shinefield H, Pulley J. A personnel time-motion study of intranasal influenza vaccination in healthy children. Vaccine. 2005 Sep 23; 23(40):4879-85. PMID: 16005551.
      View in: PubMed
    24. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005 Sep; 116(3):e397-407. PMID: 16140685; PMCID: PMC1361119.
    25. Beckham JD, Cadena A, Lin J, Piedra PA, Glezen WP, Greenberg SB, Atmar RL. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005 May; 50(4):322-30. PMID: 15845430.
      View in: PubMed
    26. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, Glezen WP. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2005 Apr; 192(4):1098-106. PMID: 15846187.
      View in: PubMed
    27. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M, Griffith M, Fewlass C, Watts M, Hessel C, Cordova J, Glezen WP. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005 Feb 18; 23(13):1540-8. PMID: 15694506.
      View in: PubMed
    28. Glezen WP. The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J. 2004 Nov; 23(11 Suppl):S202-6. PMID: 15577574.
      View in: PubMed
    29. Glezen WP. New vaccines for old diseases: trivalent cold-adapted influenza vaccine. Pediatr Ann. 2004 Aug; 33(8):545-50. PMID: 15354606.
      View in: PubMed
    30. Glezen WP, Piedra PA, Longini IM, Halloran ME. Safety of cold-adapted live influenza vaccine. Pediatr Infect Dis J. 2004 Jun; 23(6):593-4; author reply 594. PMID: 15194854.
      View in: PubMed
    31. Glezen WP. Cold-adapted, live attenuated influenza vaccine. Expert Rev Vaccines. 2004 Apr; 3(2):131-9. PMID: 15056039.
      View in: PubMed
    32. Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA, Riggs MW, Fewlass C, Halloran ME, Longini IM, Glezen WP. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med. 2004 Jan; 158(1):65-73. PMID: 14706961.
      View in: PubMed
    33. Glezen WP. Control of influenza. Tex Heart Inst J. 2004; 31(1):39-41. PMID: 15061625; PMCID: PMC387431.
    34. Halloran ME, Longini IM, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol. 2003 Aug 15; 158(4):305-11. PMID: 12915495.
      View in: PubMed
    35. Glezen WP. Session IV. Ethical, liability and regulatory issues. Vaccine. 2003 Jul 28; 21(24):3501-2. PMID: 12850369.
      View in: PubMed
    36. Englund JA, Glezen WP. Maternal immunization with Haemophilus influenzae type b vaccines in different populations. Vaccine. 2003 Jul 28; 21(24):3455-9. PMID: 12850359.
      View in: PubMed
    37. Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003 Jul 28; 21(24):3465-7. PMID: 12850361.
      View in: PubMed
    38. Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine. 2003 Jul 28; 21(24):3479-82. PMID: 12850364.
      View in: PubMed
    39. Glezen WP. Effect of maternal antibodies on the infant immune response. Vaccine. 2003 Jul 28; 21(24):3389-92. PMID: 12850346.
      View in: PubMed
    40. O'Donnell FT, Munoz FM, Atmar RL, Hwang LY, Demmler GJ, Glezen WP. Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8. Epidemiol Infect. 2003 Jun; 130(3):521-31. PMID: 12825738; PMCID: PMC2869990.
    41. Glezen WP, Couch RB. Estimating deaths due to influenza and respiratory syncytial virus. JAMA. 2003 May 21; 289(19):2500; author reply 2500-2. PMID: 12759318.
      View in: PubMed
    42. Yu J, Briles DE, Englund JA, Hollingshead SK, Glezen WP, Nahm MH. Immunogenic protein contaminants in pneumococcal vaccines. J Infect Dis. 2003 Mar 15; 187(6):1019-23. PMID: 12660950.
      View in: PubMed
    43. Munoz FM, Glezen WP. Why no effect of maternal respiratory syncytial virus-neutralizing antibody? Pediatrics. 2003 Jan; 111(1):218-20; author reply 218-20. PMID: 12509582.
      View in: PubMed
    44. Belshe RB, Couch RB, Glezen WP, Treanor JT. Live attenuated intranasal influenza vaccine. Vaccine. 2002 Oct 4; 20(29-30):3429-30. PMID: 12297386.
      View in: PubMed
    45. Glezen WP. Influenza vaccination for healthy children. Curr Opin Infect Dis. 2002 Jun; 15(3):283-7. PMID: 12015463.
      View in: PubMed
    46. Glezen WP. Influenza virus in pediatric patients. Introduction. Semin Pediatr Infect Dis. 2002 Apr; 13(2):69-70. PMID: 12122953.
      View in: PubMed
    47. Smith CB, Cox NJ, Subbarao K, Taber LH, Glezen WP. Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis. 2002 Apr 1; 185(7):980-5. PMID: 11920323.
      View in: PubMed
    48. Munoz FM, Englund JA, Cheesman CC, Maccato ML, Pinell PM, Nahm MH, Mason EO, Kozinetz CA, Thompson RA, Glezen WP. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001 Dec 12; 20(5-6):826-37. PMID: 11738746.
      View in: PubMed
    49. Glezen WP. Maternal vaccines. Prim Care. 2001 Dec; 28(4):791-806, vi-vii. PMID: 11739030.
      View in: PubMed
    50. Gaglani M, Riggs M, Kamenicky C, Glezen WP. A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J. 2001 Dec; 20(12):1155-60. PMID: 11740323.
      View in: PubMed
    51. Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr Infect Dis J. 2001 Oct; 20(10):931-40. PMID: 11642626.
      View in: PubMed
    52. Glezen WP. The new nasal spray influenza vaccine. Pediatr Infect Dis J. 2001 Aug; 20(8):731-2. PMID: 11734731.
      View in: PubMed
    53. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001 Mar 22; 344(12):889-96. PMID: 11259722.
      View in: PubMed
    54. Mbawuike IN, Wells J, Byrd R, Cron SG, Glezen WP, Piedra PA. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis. 2001 Mar 1; 183(5):687-96. PMID: 11181144.
      View in: PubMed
    55. Glezen WP. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine. 2000 Dec 8; 19 Suppl 1:S56-8. PMID: 11163464.
      View in: PubMed
    56. Englund JA, Glezen WP. Passive immunization for the prevention of otitis media. Vaccine. 2000 Dec 8; 19 Suppl 1:S116-21. PMID: 11163474.
      View in: PubMed
    57. Glezen WP. [Prevention of influenza in children]. Arch Pediatr. 2000 Oct; 7(10):1037-8. PMID: 11075256.
      View in: PubMed
    58. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis. 2000 Jul; 31(1):96-100. PMID: 10913403.
      View in: PubMed
    59. Glezen WP. Influenza and hospitalizations in children. N Engl J Med. 2000 Jun 8; 342(23):1752-3. PMID: 10858094.
      View in: PubMed
    60. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000 Jan 26; 283(4):499-505. PMID: 10659876.
      View in: PubMed
    61. Glezen WP. Pneumococcal polysaccharide vaccine in pregnancy. Pediatrics. 1999 Dec; 104(6):1417-8. PMID: 10610500.
      View in: PubMed
    62. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999 Jul 14; 282(2):137-44. PMID: 10411194.
      View in: PubMed
    63. Kaiser L, Couch RB, Galasso GJ, Glezen WP, Webster RG, Wright PF, Hayden FG. First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998. Antiviral Res. 1999 Jul; 42(3):149-75. PMID: 10443529.
      View in: PubMed
    64. Glezen WP. Influenza control--unfinished business. JAMA. 1999 Mar 10; 281(10):944-5. PMID: 10078494.
      View in: PubMed
    65. Glezen WP, Alpers M. Maternal immunization. Clin Infect Dis. 1999 Feb; 28(2):219-24. PMID: 10064230.
      View in: PubMed
    66. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. 1998 Aug-Sep; 16(14-15):1456-63. PMID: 9711788.
      View in: PubMed
    67. Glezen WP. Prevention of neonatal tetanus. Am J Public Health. 1998 Jun; 88(6):871-2. PMID: 9618609; PMCID: PMC1508217.
    68. Englund JA, Glezen WP, Thompson C, Anwaruddin R, Turner CS, Siber GR. Haemophilus influenzae type b-specific antibody in infants after maternal immunization. Pediatr Infect Dis J. 1997 Dec; 16(12):1122-30. PMID: 9427456.
      View in: PubMed
    69. Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB. Dual respiratory virus infections. Clin Infect Dis. 1997 Dec; 25(6):1421-9. PMID: 9431390.
      View in: PubMed
    70. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J. 1997 Nov; 16(11):1065-8. PMID: 9384341.
      View in: PubMed
    71. Glezen WP. Commentary on the revised vaccine injury table. Pediatrics. 1996 Dec; 98(6 Pt 1):1200-1. PMID: 8951280.
      View in: PubMed
    72. Park MK, Englund JA, Glezen WP, Siber GR, Nahm MH. Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions. Vaccine. 1996 Sep; 14(13):1219-22. PMID: 8961508.
      View in: PubMed
    73. Glezen WP. Structured guidelines for the use of influenza vaccine among children. Pediatr Infect Dis J. 1996 Sep; 15(9):840-1. PMID: 8878237.
      View in: PubMed
    74. Suara RO, Piedra PA, Glezen WP, Adegbola RA, Weber M, Mulholland EK, Greenwood BM, Whittle H. Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. Clin Diagn Lab Immunol. 1996 Jul; 3(4):477-9. PMID: 8807217; PMCID: PMC170373.
    75. Mulholland K, Suara RO, Siber G, Roberton D, Jaffar S, N'Jie J, Baden L, Thompson C, Anwaruddin R, Dinan L, Glezen WP, Francis N, Fritzell B, Greenwood BM. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA. 1996 Apr 17; 275(15):1182-8. PMID: 8609686.
      View in: PubMed
    76. Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996 Jan; 22(1):100-6. PMID: 8824973.
      View in: PubMed
    77. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev. 1996; 18(1):64-76. PMID: 8877331.
      View in: PubMed
    78. Piedra PA, Glezen WP, Kasel JA, Welliver RC, Jewel AM, Rayford Y, Hogerman DA, Hildreth SW, Paradiso PR. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine. 1995 Aug; 13(12):1095-101. PMID: 7491817.
      View in: PubMed
    79. Langlois PH, Smolensky MH, Glezen WP, Keitel WA. Diurnal variation in responses to influenza vaccine. Chronobiol Int. 1995 Feb; 12(1):28-36. PMID: 7750155.
      View in: PubMed
    80. Englund JA, Glezen WP, Turner C, Harvey J, Thompson C, Siber GR. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis. 1995 Jan; 171(1):99-105. PMID: 7798688.
      View in: PubMed
    81. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 1993 Sep; 168(3):647-56. PMID: 8354906.
      View in: PubMed
    82. Glezen WP. Influenza surveillance in an urban area. Can J Infect Dis. 1993 Sep; 4(5):272-4. PMID: 22346461; PMCID: PMC3250750.
    83. Glezen WP. Indications for amantadine in otherwise healthy children. Pediatr Infect Dis J. 1993 Jan; 12(1):106. PMID: 8417417.
      View in: PubMed
    84. Piedra PA, Glezen WP, Mbawuike I, Gruber WC, Baxter BD, Boland FJ, Byrd RW, Fan LL, Lewis JK, Rhodes LJ, et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine. 1993; 11(7):718-24. PMID: 8342319.
      View in: PubMed
    85. Englund JA, Glezen WP, Barreto L. Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J Infect Dis. 1992 Dec; 166(6):1436-41. PMID: 1431261.
      View in: PubMed
    86. Glezen WP, Englund JA, Siber GR, Six HR, Turner C, Shriver D, Hinkley CM, Falcao O. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b. J Infect Dis. 1992 Jun; 165 Suppl 1:S134-6. PMID: 1588147.
      View in: PubMed
    87. Troendle JF, Demmler GJ, Glezen WP, Finegold M, Romano MJ. Fatal influenza B virus pneumonia in pediatric patients. Pediatr Infect Dis J. 1992 Feb; 11(2):117-21. PMID: 1741181.
      View in: PubMed
    88. Glezen WP. Viral respiratory infections. Pediatr Ann. 1991 Aug; 20(8):407-12. PMID: 1945538.
      View in: PubMed
    89. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991 Feb; 163(2):300-4. PMID: 1988512.
      View in: PubMed
    90. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol. 1991 Feb 1; 133(3):296-304. PMID: 2000847.
      View in: PubMed
    91. Glezen WP, Falcao O, Cate TR, Mintz AA. Nosocomial influenza in a general hospital for indigent patients. Can J Infect Control. 1991; 6(3):65-7. PMID: 1824284.
      View in: PubMed
    92. Glezen WP. Epidemiological perspective of breastfeeding and acute respiratory illnesses in infants. Adv Exp Med Biol. 1991; 310:235-40. PMID: 1809003.
      View in: PubMed
    93. Glezen WP. Morbidity associated with the major respiratory viruses. Pediatr Ann. 1990 Sep; 19(9):535-6, 538, 540, passim. PMID: 2172898.
      View in: PubMed
    94. Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, Couch RB. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990 May; 144(5):595-600. PMID: 2330929.
      View in: PubMed
    95. Glezen WP. Antecedents of chronic and recurrent lung disease. Childhood respiratory trouble. Am Rev Respir Dis. 1989 Oct; 140(4):873-4. PMID: 2802375.
      View in: PubMed
    96. Glezen WP. Influenza immunization of elderly. J Fam Pract. 1988 Sep; 27(3):253, 256, 258. PMID: 3418297.
      View in: PubMed
    97. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987 Sep; 136(3):550-5. PMID: 3631727.
      View in: PubMed
    98. Khamapirad T, Glezen WP. Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children. Semin Respir Infect. 1987 Jun; 2(2):130-44. PMID: 3321271.
      View in: PubMed
    99. Glezen WP, Decker M, Joseph SW, Mercready RG. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis. 1987 Jun; 155(6):1119-26. PMID: 3572033.
      View in: PubMed
    100. Kasel JA, Walsh EE, Frank AL, Baxter BD, Taber LH, Glezen WP. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunol. 1987-1988; 1(3):199-205. PMID: 3509676.
      View in: PubMed
    101. Glezen WP. The pediatrician's role in influenza control. Pediatr Infect Dis. 1986 Nov-Dec; 5(6):615-8. PMID: 3797294.
      View in: PubMed
    102. Clover RD, Crawford SA, Abell TD, Ramsey CN, Glezen WP, Couch RB. Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child. 1986 Jul; 140(7):706-9. PMID: 3521258.
      View in: PubMed
    103. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986 Jun; 140(6):543-6. PMID: 3706232.
      View in: PubMed
    104. Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber LH, Frank AL, Greenberg SB, Zahradnik JM, Keitel WA. Influenza: its control in persons and populations. J Infect Dis. 1986 Mar; 153(3):431-40. PMID: 3950437.
      View in: PubMed
    105. Glezen WP. Influenza B and staphylococcal pneumonia. J Pediatr. 1985 Oct; 107(4):651-2. PMID: 4045624.
      View in: PubMed
    106. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol. 1985 Sep; 122(3):468-76. PMID: 4025296.
      View in: PubMed
    107. Taylor JP, Gustafson TL, Johnson CC, Brandenburg N, Glezen WP. Antipyretic use among children during the 1983 influenza season. Am J Dis Child. 1985 May; 139(5):486-8. PMID: 3984974.
      View in: PubMed
    108. Yanagihara R, Chin CT, Weiss MB, Gajdusek DC, Diwan AR, Poland JB, Kleeman KT, Wilfert CM, Meiklejohn G, Glezen WP. Serological evidence of Hantaan virus infection in the United States. Am J Trop Med Hyg. 1985 Mar; 34(2):396-9. PMID: 2858988.
      View in: PubMed
    109. Glezen WP, Frank AL, Taber LH, Kasel JA. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis. 1984 Dec; 150(6):851-7. PMID: 6094674.
      View in: PubMed
    110. Kasel JA, Frank AL, Keitel WA, Taber LH, Glezen WP. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol. 1984 Dec; 52(3):828-32. PMID: 6092715; PMCID: PMC254602.
    111. Glezen WP. Reactive airway disorders in children. Role of respiratory virus infections. Clin Chest Med. 1984 Dec; 5(4):635-43. PMID: 6394199.
      View in: PubMed
    112. Glezen WP, Glezen LS, Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child. 1983 Nov; 137(11):1095-7. PMID: 6637914.
      View in: PubMed
    113. Six HR, Webster RG, Kendal AP, Glezen WP, Griffis C, Couch RB. Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons. Infect Immun. 1983 Nov; 42(2):453-8. PMID: 6642637; PMCID: PMC264451.
    114. Frank AL, Taber LH, Glezen WP, Geyer EA, McIlwain S, Paredes A. Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol. 1983 Sep; 118(3):313-25. PMID: 6613976.
      View in: PubMed
    115. Wright PF, Cherry JD, Foy HM, Glezen WP, Hall CB, McIntosh K, Monto AS, Parrott RH, Portnoy B, Taber LH. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. Rev Infect Dis. 1983 Jul-Aug; 5(4):758-64. PMID: 6353530.
      View in: PubMed
    116. Glezen WP. Viral pneumonia as a cause and result of hospitalization. J Infect Dis. 1983 Apr; 147(4):765-70. PMID: 6302174.
      View in: PubMed
    117. Glezen WP. [Influence of influenza epidemics on the urban population]. Vopr Virusol. 1983 Mar-Apr; (2):170-6. PMID: 6868555.
      View in: PubMed
    118. Velazco JG, Couch RB, Six HR, Glezen WP. Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. Bull World Health Organ. 1983; 61(2):345-52. PMID: 6190585; PMCID: PMC2536122.
    119. Glezen WP. Aspirin and Reye's syndrome. Am J Dis Child. 1982 Nov; 136(11):971-2. PMID: 7124701.
      View in: PubMed
    120. Glezen WP, Couch RB, Six HR. The influenza herald wave. Am J Epidemiol. 1982 Oct; 116(4):589-98. PMID: 7137146.
      View in: PubMed
    121. Glezen WP, Payne AA, Snyder DN, Downs TD. Mortality and influenza. J Infect Dis. 1982 Sep; 146(3):313-21. PMID: 7108280.
      View in: PubMed
    122. Frank AL, Taber LH, Glezen WP, Kasel GL, Wells CR, Paredes A. Breast-feeding and respiratory virus infection. Pediatrics. 1982 Aug; 70(2):239-45. PMID: 7099789.
      View in: PubMed
    123. Harmon AT, Harmon MW, Glezen WP. Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3. Am Rev Respir Dis. 1982 Jun; 125(6):706-11. PMID: 6178328.
      View in: PubMed
    124. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982; 4:25-44. PMID: 6754408.
      View in: PubMed
    125. Kimmel KA, Wyde PR, Glezen WP. Evidence of a T-cell-mediated cytotoxic response to parainfluenza virus type 3 pneumonia in hamsters. J Reticuloendothel Soc. 1982 Jan; 31(1):71-83. PMID: 6278144.
      View in: PubMed
    126. Glezen WP. Prevention of influenza-related morbidity and mortality. Arch Intern Med. 1982 Jan; 142(1):25-6. PMID: 7053731.
      View in: PubMed
    127. Anderson P, Insel RA, Smith DH, Cate TR, Couch RB, Glezen WP. A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults. J Infect Dis. 1981 Dec; 144(6):530-8. PMID: 7035578.
      View in: PubMed
    128. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis. 1981 Nov; 144(5):433-41. PMID: 6273473.
      View in: PubMed
    129. Taber LH, Paredes A, Glezen WP, Couch RB. Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond). 1981 Jun; 86(3):303-13. PMID: 7016989; PMCID: PMC2133985.
    130. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981 May; 98(5):708-15. PMID: 7229749.
      View in: PubMed
    131. Glezen WP. [Surveillance for influenza virus infections in Houston, Texas (author's transl)]. Rev Med Chil. 1981 Feb; 109(2):173-7. PMID: 7268257.
      View in: PubMed
    132. Frank AL, Webster RG, Glezen WP, Cate TR. Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults. J Med Virol. 1981; 7(2):135-42. PMID: 7264612.
      View in: PubMed
    133. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis. 1980 Dec; 142(6):844-9. PMID: 7462695.
      View in: PubMed
    134. Glezen WP. Influenza C virus infection. Arch Intern Med. 1980 Oct; 140(10):1278. PMID: 7425761.
      View in: PubMed
    135. Glezen WP. Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis. 1980 May-Jun; 2(3):408-20. PMID: 6997968.
      View in: PubMed
    136. Glezen WP, Paredes A, Taber LH. Influenza in children. Relationship to other respiratory agents. JAMA. 1980 Apr 4; 243(13):1345-9. PMID: 6244421.
      View in: PubMed
    137. Glezen WP, Couch RB, Taber LH, Paredes A, Allison JE, Frank AL, Aldridge C. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol. 1980 Jan; 111(1):13-22. PMID: 7352453.
      View in: PubMed
    138. Frank AL, Taber LH, Glezen WP, Paredes A, Couch RB. Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis. 1979 Dec; 140(6):829-36. PMID: 541521.
      View in: PubMed
    139. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978 Mar 16; 298(11):587-92. PMID: 628375.
      View in: PubMed
    140. Webster RG, Glezen WP, Hannoun C, Laver WG. Potentiation of the immune response to influenza virus subunit vaccines. J Immunol. 1977 Dec; 119(6):2073-7. PMID: 915292.
      View in: PubMed
    141. Allison JE, Glezen WP, Taber LH, Paredes A, Webster RG. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J Infect Dis. 1977 Dec; 136 Suppl:S672-6. PMID: 606790.
      View in: PubMed
    142. Glezen WP, Kasel JA, Webster RG, Taber LH. Alternative approaches to immunization of children with inactivated influenza virus vaccines. J Infect Dis. 1977 Dec; 136 Suppl:S677-82. PMID: 606791.
      View in: PubMed
    143. Webster RG, Glezen WP, Kasel JA, Laver WG. Potentiation of the immune response to influenza virus subunit vaccines. Dev Biol Stand. 1977 Jun 1-3; 39:243-8. PMID: 604104.
      View in: PubMed
    144. Glezen WP. Influenza prophylaxis for children. Am J Dis Child. 1977 Jun; 131(6):928-30. PMID: 868829.
      View in: PubMed
    145. Glezen WP. Pathogenesis of bronchiolitis--epidemiologic considerations. Pediatr Res. 1977 Mar; 11(3 Pt 2):239-43. PMID: 322074.
      View in: PubMed
    146. Klein JD, Collier AM, Glezen WP. An influenza B epidemic among children in day-care. Pediatrics. 1976 Sep; 58(3):340-5. PMID: 958761.
      View in: PubMed
    147. Glezen WP, Fernald GW. Effect of passive antibody on parainfluenza virus type 3 pneumonia in hamsters. Infect Immun. 1976 Jul; 14(1):212-6. PMID: 181324; PMCID: PMC420865.
    148. Denny FW, Glezen WP, Karzon DT, Katz SL, Krugman S, McIntosh K, Parrott RH. Swine-like influenza vaccine: a commentary. J Pediatr. 1976 Jun; 88(6):1057. PMID: 944768.
      View in: PubMed
    149. Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA, Denny FW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr. 1975 Dec; 87(6 Pt 2):1087-93. PMID: 241779.
      View in: PubMed
    150. Glezen WP, Fernald GW, Lohr JA. Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am J Epidemiol. 1975 Feb; 101(2):111-21. PMID: 164768.
      View in: PubMed
    151. Loda FA, Glezen WP. Parainfluenza virus infections. Prev Med. 1974 Dec; 3(4):481-7. PMID: 4373703.
      View in: PubMed
    152. Glezen WP. Infection and chronic granulomatous disease. J Pediatr. 1974 Jan; 84(1):160-1; author reply 161. PMID: 12119947.
      View in: PubMed
    153. Sarubbi FA, Sparling PF, Glezen WP. Herpesvirus hominis encephalitis. Virus isolation from brain biopsy in seven patients and results of therapy. Arch Neurol. 1973 Oct; 29(4):268-73. PMID: 4353848.
      View in: PubMed
    154. Fernald GW, Glezen WP. Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae vaccine in children. J Infect Dis. 1973 May; 127(5):498-504. PMID: 4698637.
      View in: PubMed
    155. Glezen WP. Common viral diseases of childhood. Am Fam Physician. 1972 Nov; 6(5):122-8. PMID: 4343860.
      View in: PubMed
    156. Loda FA, Glezen WP, Clyde WA. Respiratory disease in group day care. Pediatrics. 1972 Mar; 49(3):428-37. PMID: 4334560.
      View in: PubMed
    157. Glezen WP, Lindsay RL, DeWalt JL, Dillon HC. Epidemic pyoderma caused by nephritogenic streptococci in college athletes. Lancet. 1972 Feb 5; 1(7745):301-3. PMID: 4109941.
      View in: PubMed
    158. Glezen WP, Loda FA, Clyde WA, Senior RJ, Sheaffer CI, Conley WG, Denny FW. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971 Mar; 78(3):397-406. PMID: 5101436.
      View in: PubMed
    159. Denny FW, Clyde WA, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis. 1971 Jan; 123(1):74-92. PMID: 5100980.
      View in: PubMed
    160. Glezen WP, McCollough RH, Lamb GA, Chin TD. Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine. Am J Epidemiol. 1969 Aug; 90(2):146-56. PMID: 4308600.
      View in: PubMed
    161. McCollough RH, Glezen WP, Lamb GA, Chin TD. Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine. Am J Dis Child. 1969 Feb; 117(2):161-8. PMID: 4303394.
      View in: PubMed
    162. Glezen WP, Loda FA, Denny FW. A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69. Bull World Health Organ. 1969; 41(3):566-9. PMID: 5309478; PMCID: PMC2427763.
    163. Loda FA, Clyde WA, Glezen WP, Senior RJ, Sheaffer CI, Denny FW. Studies on the role of viruses, bacteria, and M. pneumoniae as causes of lower respiratory tract infections in children. J Pediatr. 1968 Feb; 72(2):161-76. PMID: 4384200.
      View in: PubMed
    164. Glezen WP, Clyde WA, Senior RJ, Sheaffer CI, Denny FW. Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA. 1967 Nov 6; 202(6):455-60. PMID: 4293014.
      View in: PubMed
    165. Glezen WP, Wulff H, Lamb GA, Ray CG, Chin TD, Wenner HA. Patterns of virus infections in families with acute respiratory illnesses. Am J Epidemiol. 1967 Sep; 86(2):350-61. PMID: 6058392.
      View in: PubMed
    166. Saliba GS, Glezen WP, Chin TD. Mycoplasma pneumoniae infection in a resident boys' home. Am J Epidemiol. 1967 Sep; 86(2):408-18. PMID: 6058394.
      View in: PubMed
    167. Stites DP, Glezen WP. Pulmonary nocardiosis in childhood. A case report. Am J Dis Child. 1967 Jul; 114(1):101-5. PMID: 4952772.
      View in: PubMed
    168. Saliba GS, Glezen WP, Chin TD. Etiologic studies of acute respiratory illness among children attending public schools. Am Rev Respir Dis. 1967 Apr; 95(4):592-602. PMID: 6021120.
      View in: PubMed
    169. Glezen WP, Thornburg G, Chin TD, Wenner HA. Significance of mycoplasma infections in children with respiratory disease. Pediatrics. 1967 Apr; 39(4):516-25. PMID: 6022929.
      View in: PubMed
    170. Ray CG, McCollough RH, Doto IL, Todd JC, Glezen WP, Chin TD. Echo 4 illness. Epidemiological, clinical and laboratory studies of an outbreak in a rural community. Am J Epidemiol. 1966 Sep; 84(2):253-67. PMID: 5917607.
      View in: PubMed
    171. Glezen WP, Hines MP, Kerbaugh M, Green ME, Koomen J. Salmonella in two poultry processing plants. J Am Vet Med Assoc. 1966 Mar 1; 148(5):550-2. PMID: 5331690.
      View in: PubMed
    172. Glezen WP, Lamb GA, Belden EA, Chin TD. Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol. 1966 Mar; 83(2):224-37. PMID: 5930775.
      View in: PubMed
    173. LAMB GA, PLEXICO K, GLEZEN WP, CHIN TD. USE OF MICRO TECHNIQUE FOR SERUM NEUTRALIZATION AND VIRUS IDENTIFICATION. Public Health Rep. 1965 May; 80:463-6. PMID: 14290598; PMCID: PMC1919535.
    GLEZEN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _